ATRA vs EW · rev $128.9M vs P/E 47, rev $1.39B
Atara Biotherapeutics Inc (ATRA) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
ATRA currently screens at market cap $87.1M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the ATRA and EW stock pages for the full models.
Not investment advice.